illumigyn, an Israeli medtech, or femtech, startup that offers first remote gynecological imaging platform, has raised $33 million to date, following the closure of its latest round of investment which included the Yozma Group Korea and Ubicom Holdings Japan.
The company is yet another new one to come out of Startup Nation that concentrates on healthcare needs specific to women. Some call this field femtech. Femtech is a form of Medtech. Until now, the Femtech developers and medical specialists who have worked in women’s medicine have mostly been men. OCON wants to change that.
OCON Healthcare, for example, is an Israeli femtech startup that manufactures and commercializes innovative 3D intrauterine devices (IUD) for women who wish to conceive based on its patented IUB (Intra-Uterine Ball) platform.
Founded in 2012 by Ran Poliakine and Lior Greenstein, illumigyn focuses on women’s health and making it “accessible and affordable for every woman worldwide.” illumigyn has the first FDA-cleared remote gynecological platform, the Gynescope. It digitally documents the cervix, vagina, and external genitalia. High-quality resolution and superior magnification enhance details beyond the capabilities of traditional cervix exams, enabling more accurate pap smears.
The illumigyn Gynescope, boasts the company, can be handled by any trained caregiver (OB/GYN, GP, Midwife, Nurse Practitioner, and Physician Assistant) so that women of all individual sensitivities can be assessed in a safe space. The HIPAA-compliant solution automatically uploads and securely stores images to the cloud. This allows a doctor or specialist to view the images remotely and provides women with access to their scans and doctors’ recommendations.
— illumigyn (@illumigyn) November 2, 2021
“This is another milestone in our vision to democratize women’s healthcare and bring advanced gynecological care to women worldwide,” said Mr. Ran Poliakine, illumigyn’s Founder. “Our deployments this month are aligned with our mission to bring our platform to women everywhere, in developed and developing countries, in population centers, as well as remote communities. This is our mission and our commitment.”
“We are proud to introduce to the world a cutting-edge innovation that will ensure that women all over the world will feel safe during gynecological exams and will have access to all of their medical information,” Dr. Avi Ludomirski, CEO and Chairman of the Board of illumigyn. “The funding secured by the company will be deployed to ramp up production and will enable illumigyn to execute existing distribution agreements and sign additional new global partnerships.”